SILVER SPRING, Md., Nov. 29, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Cytalux (pafolacianine), an imaging drug intended to assist surgeons in identifying ovarian cancer lesions. The drug is designed to improve the ability to...
